PILLAR RANKING • November 11, 2026
verified
Highest Quality: State Rankings
Ranked by five CMS resident-outcome measures: antipsychotic use, pressure ulcers, falls with major injury, hospitalizations and readmissions.
Top 3 States
Browse Other Pillars
All 51 States Ranked
Higher score = better| Rank | State | Grade | Score | Details | |
|---|---|---|---|---|---|
| #1 | Hawaii | A | 91.2 | 12.4% antipsychotic use · 1.07 hospitalizations per 1,000 days | View → |
| #2 | Utah | A | 86.6 | 13.8% antipsychotic use · 1.17 hospitalizations per 1,000 days | View → |
| #3 | District of Columbia | A | 76.7 | 8.6% antipsychotic use · 1.26 hospitalizations per 1,000 days | View → |
| #4 | Idaho | A | 76.0 | 20.3% antipsychotic use · 1.03 hospitalizations per 1,000 days | View → |
| #5 | Washington | A | 72.6 | 15.0% antipsychotic use · 1.26 hospitalizations per 1,000 days | View → |
| #6 | Arizona | A | 69.8 | 10.6% antipsychotic use · 1.46 hospitalizations per 1,000 days | View → |
| #7 | Delaware | A | 67.7 | 10.6% antipsychotic use · 1.75 hospitalizations per 1,000 days | View → |
| #8 | Ohio | A | 67.0 | 8.5% antipsychotic use · 1.65 hospitalizations per 1,000 days | View → |
| #9 | Indiana | B | 63.2 | 13.7% antipsychotic use · 1.51 hospitalizations per 1,000 days | View → |
| #10 | Colorado | B | 63.1 | 19.9% antipsychotic use · 1.38 hospitalizations per 1,000 days | View → |
| #11 | Maryland | B | 62.7 | 14.1% antipsychotic use · 1.30 hospitalizations per 1,000 days | View → |
| #12 | Virginia | B | 59.2 | 14.2% antipsychotic use · 1.44 hospitalizations per 1,000 days | View → |
| #13 | California | B | 57.5 | 12.3% antipsychotic use · 2.21 hospitalizations per 1,000 days | View → |
| #14 | Alaska | B | 57.4 | 18.9% antipsychotic use · 1.00 hospitalizations per 1,000 days | View → |
| #15 | Oregon | B | 56.8 | 14.3% antipsychotic use · 1.46 hospitalizations per 1,000 days | View → |
| #16 | West Virginia | B | 56.2 | 12.9% antipsychotic use · 1.58 hospitalizations per 1,000 days | View → |
| #17 | Maine | C | 54.7 | 19.5% antipsychotic use · 1.26 hospitalizations per 1,000 days | View → |
| #18 | Pennsylvania | C | 53.6 | 17.6% antipsychotic use · 1.50 hospitalizations per 1,000 days | View → |
| #19 | Florida | C | 53.6 | 8.7% antipsychotic use · 2.04 hospitalizations per 1,000 days | View → |
| #20 | Texas | C | 53.4 | 9.8% antipsychotic use · 2.05 hospitalizations per 1,000 days | View → |
| #21 | Iowa | C | 52.8 | 19.8% antipsychotic use · 1.45 hospitalizations per 1,000 days | View → |
| #22 | New Mexico | C | 52.7 | 14.5% antipsychotic use · 1.49 hospitalizations per 1,000 days | View → |
| #23 | Wisconsin | C | 50.7 | 15.9% antipsychotic use · 1.57 hospitalizations per 1,000 days | View → |
| #24 | Wyoming | C | 50.7 | 21.4% antipsychotic use · 1.33 hospitalizations per 1,000 days | View → |
| #25 | Arkansas | C | 50.7 | 10.9% antipsychotic use · 1.94 hospitalizations per 1,000 days | View → |
| #26 | Nevada | C | 50.5 | 17.1% antipsychotic use · 1.81 hospitalizations per 1,000 days | View → |
| #27 | Tennessee | C | 48.9 | 17.0% antipsychotic use · 1.60 hospitalizations per 1,000 days | View → |
| #28 | New York | C | 48.4 | 13.7% antipsychotic use · 1.67 hospitalizations per 1,000 days | View → |
| #29 | New Jersey | C | 48.0 | 12.9% antipsychotic use · 1.96 hospitalizations per 1,000 days | View → |
| #30 | North Carolina | C | 47.8 | 13.9% antipsychotic use · 1.69 hospitalizations per 1,000 days | View → |
| #31 | Michigan | C | 47.5 | 14.7% antipsychotic use · 1.74 hospitalizations per 1,000 days | View → |
| #32 | Connecticut | C | 44.4 | 17.7% antipsychotic use · 1.93 hospitalizations per 1,000 days | View → |
| #33 | Nebraska | C | 43.9 | 20.7% antipsychotic use · 1.67 hospitalizations per 1,000 days | View → |
| #34 | Kansas | C | 43.9 | 17.7% antipsychotic use · 1.69 hospitalizations per 1,000 days | View → |
| #35 | New Hampshire | C | 43.3 | 17.9% antipsychotic use · 1.72 hospitalizations per 1,000 days | View → |
| #36 | Minnesota | D | 42.1 | 17.2% antipsychotic use · 1.54 hospitalizations per 1,000 days | View → |
| #37 | South Carolina | D | 40.9 | 15.4% antipsychotic use · 1.95 hospitalizations per 1,000 days | View → |
| #38 | Kentucky | D | 39.7 | 16.2% antipsychotic use · 1.88 hospitalizations per 1,000 days | View → |
| #39 | Rhode Island | D | 39.2 | 22.5% antipsychotic use · 1.59 hospitalizations per 1,000 days | View → |
| #40 | South Dakota | D | 39.0 | 24.8% antipsychotic use · 1.51 hospitalizations per 1,000 days | View → |
| #41 | North Dakota | D | 38.8 | 22.8% antipsychotic use · 1.46 hospitalizations per 1,000 days | View → |
| #42 | Vermont | D | 36.0 | 20.0% antipsychotic use · 1.45 hospitalizations per 1,000 days | View → |
| #43 | Montana | D | 35.7 | 20.7% antipsychotic use · 1.39 hospitalizations per 1,000 days | View → |
| #44 | Massachusetts | D | 34.9 | 21.5% antipsychotic use · 1.84 hospitalizations per 1,000 days | View → |
| #45 | Illinois | F | 31.4 | 21.7% antipsychotic use · 1.96 hospitalizations per 1,000 days | View → |
| #46 | Alabama | F | 31.2 | 21.3% antipsychotic use · 1.86 hospitalizations per 1,000 days | View → |
| #47 | Georgia | F | 28.2 | 19.8% antipsychotic use · 2.07 hospitalizations per 1,000 days | View → |
| #48 | Missouri | F | 24.6 | 23.5% antipsychotic use · 1.98 hospitalizations per 1,000 days | View → |
| #49 | Oklahoma | F | 20.2 | 17.8% antipsychotic use · 2.19 hospitalizations per 1,000 days | View → |
| #50 | Louisiana | F | 14.6 | 22.8% antipsychotic use · 2.43 hospitalizations per 1,000 days | View → |
| #51 | Mississippi | F | 14.0 | 21.8% antipsychotic use · 2.31 hospitalizations per 1,000 days | View → |
Scores are 0–100 relative to other states. Pillar grades are assigned by within-pillar rank position. Read methodology →